| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 2,058,274 | 1,531,408 | 1,105,607 | 1,743,801 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,058,274 | 1,531,408 | 1,105,607 | 1,743,801 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,562,304 | 1,434,848 | 1,494,928 | 1,870,056 | | Non Recurring |
-
|
-
| 989,971 |
-
| | Others | 333,269 | 465 | 742 | 1,386 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 162,701 | 96,095 | (1,380,034) | (127,641) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (17,285) | 24,624 | 1,595,842 | (1,411,388) | | Earnings Before Interest And Taxes | 138,077 | 120,719 | (1,236,839) | (86,382) | | Interest Expense | 54,198 | 61,341 | 84,247 | 78,000 | | Income Before Tax | 83,879 | 59,378 | (1,321,086) | (164,382) | | Income Tax Expense | 16,045 | 45,953 | 92,828 | 47,843 | | Minority Interest | 40 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 85,541 | 3,097 | (1,419,513) | (1,616,524) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 85,541 | 3,097 | (1,419,513) | (1,616,524) | | Preferred Stock And Other Adjustments | (5,592) | 175,282 | (13,645) | (32,500) | | | Net Income Applicable To Common Shares | $79,949 | $178,379 | ($1,433,158) | ($1,649,024) |
|
0.17% Nasdaq 
Income Statement
